Concomitant pulmonary infection with Nocardia transvalensis and Aspergillus ustus in lung transplantation

Journal of Heart and Lung Transplantation

Volumn 29, Issue 8, 2010, Pages 900-903

  Cabada, Miguel M ^a   Nishi, Shawn P ^a   Lea, Alfred S ^a   Schnadig, Vicki ^b   Lombard, Gisele A ^a   Lick, Scott D ^b   Valentine, Vincent G ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

aspergillus; lung transplantation; Nocardia; opportunistic pathogens; resistant organisms

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANIDULAFUNGIN; AZATHIOPRINE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; ITRACONAZOLE; LINEZOLID; PREDNISONE; SULFAMETHOXAZOLE; TACROLIMUS; THYMOCYTE ANTIBODY; TRIMETHOPRIM; VALGANCICLOVIR; VORICONAZOLE;

AGED; ANOREXIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS USTUS; BACTERIUM CULTURE; BACTERIUM ISOLATE; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPNEA; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG FUNCTION; LUNG INFECTION; LUNG LAVAGE; LUNG LOBE; LUNG TRANSPLANTATION; MALE; NOCARDIA; NOCARDIA TRANSVALENSIS; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; ANTI-INFECTIVE AGENTS; ASPERGILLUS; COMORBIDITY; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOSUPPRESSION; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; NOCARDIA; NOCARDIA INFECTIONS; OPPORTUNISTIC INFECTIONS; PULMONARY ASPERGILLOSIS; TREATMENT OUTCOME;

EID: 77955714511     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.04.016     Document Type: Article

References (19)

1. J.D. Christie, L.B. Edwards, and P. Aurora The registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult lung and heartlung transplantation report2009 J Heart Lung Transplant 28 2009 1031 1049
2. H.K. Poonyagariyagorn, A. Gershman, and R. Avery Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients Transplant Infect Dis 10 2008 403 408
3. S.A. Roberts, J.C. Franklin, and A. Mijch Nocardia infection in heartlung transplant recipients at Alfred Hospital, Melbourne, Australia, 1989-1998 Clin Infect Dis 31 2000 968 972
4. A. Minari, R. Husni, and R.K. Avery The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants Transplant Infect Dis 4 2002 195 200
5. A.N. Malani, and C.A. Kauffman Changing epidemiology of rare mould infections: implications for therapy Drugs 67 2007 1803 1812
6. P.A. Vagefi, A.B. Cosimi, and L.C. Ginns Cutaneous Aspergillus ustus in a lung transplant recipient: emergence of a new opportunistic fungal pathogen J Heart Lung Transplant 27 2008 131 134
7. J. Pavie, C. Lacroix, and D.G. Hermoso Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis J Clin Microbiol 43 2005 4902 4904
8. V.G. Valentine, R.W. Bonvillain, and M.R. Gupta Infections in lung allograft recipients: ganciclovir era J Heart Lung Transplant 27 2008 528 535
9. V.G. Valentine, M.R. Gupta, and J.E. Walker Jr Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome J Heart Lung Transplant 28 2009 163 169
10. A. Sol, P. Morant, and M. Salavert Aspergillus infections in lung transplant recipients: risk factors and outcome Clin Microbiol Infect 11 2005 359 365
11. N. Singh, A.P. Limaye, and G. Forrest Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study Transplantation 81 2006 320 326
12. P. Garca-Martos, L. Garca-Agudo, and J. Gutirrez-Calzada In vitro activity of amphotericin B, itraconazole and voriconazole against 20 species of Aspergillus using the Sensititre microdilution method Enferm Infecc Microbiol Clin 23 2005 15 18
13. C.H. Hui, V.W. Au, and K. Rowland Pulmonary nocardiosis re-visited: experience of 35 patients at diagnosis Respir Med 97 2003 709 717
14. A.I. Peleg, S. Husain, and Z.A. Qureshi Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched casecontrol study Clin Infect Dis 44 2007 1307 1314
15. M.M. McNeil, J.M. Brown, and P.R. Georghiou Infections due to Nocardia transvalensis: clinical spectrum and antimicrobial therapy Clin Infect Dis 15 1992 453 463
16. B.A. Khan, M. Duncan, and J. Reynolds Nocardia infection in lung transplant recipients Clin Transplant 22 2008 562 566
17. Y. Glupczynski, C. Berhin, and M. Janssens Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest Clin Microbiol Infect 12 2006 905 912
18. F.A. Lopez, F. Johnson, and D.M. Novosad Successful management of disseminated Nocardia transvalensis infection in a heart transplant recipient after development of sulfonamide resistance: case report and review J Heart Lung Transplant 22 2003 492 497
19. K. Kanemitsu, H. Kunishima, and T. Saga Efficacy of Amikacin combinations for nocardiosis Tohoku J Exp Med 201 2003 157 163